Endo, Akari
Hirose, Takuo
Sato, Shigemitsu
Ito, Hiroki
Takahashi, Chika
Ishikawa, Risa
Kamada, Ayaka
Oba-Yabana, Ikuko
Kimura, Tomoyoshi
Takahashi, Kazuhiro
Mori, Takefumi
Article History
Received: 31 July 2023
Revised: 10 September 2023
Accepted: 10 September 2023
First Online: 25 September 2023
Compliance with ethical standards
:
: The Division of Integrative Renal Replacement Therapy (TH, SS, CT, and TM) is financially supported by Chugai Pharmaceutical Co., Ltd; Terumo Corporation; and JMS Co., Ltd. All the other authors declared no competing interests.